Stada Group
Yulia Eremina has a diverse work experience in various roles and companies. Yulia currently works in STADA Group as the Head of Sales Planning and Analytics, responsible for the Sales Planning Division of the Commercial Department. Prior to that, they worked at BD as a Business Analyst, where they implemented local analytics for the representative office in Russia and developed a new pricing strategy. Before that, they worked at Bayer as an Analyst, providing analytical support to the PhChain management department and developing a budget control tool. Yulia also worked as a Coordinator in the Trade Marketing Department at Dr. Theiss Naturwaren Rus, where they reported sales forces visiting activity and tracked sales of new and promoted products.
Yulia Eremina attended Moscow State Industrial University (MSIU) until 2013. Yulia obtained a certification in Data Analysis in PowerBI from the Specialist Training Center at N.E. Bauman Moscow State Technical University in 2021.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.